A. Elli

705 total citations
47 papers, 547 citations indexed

About

A. Elli is a scholar working on Transplantation, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Elli has authored 47 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Transplantation, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in A. Elli's work include Renal Transplantation Outcomes and Treatments (20 papers), Renal and Vascular Pathologies (13 papers) and Neurological Complications and Syndromes (8 papers). A. Elli is often cited by papers focused on Renal Transplantation Outcomes and Treatments (20 papers), Renal and Vascular Pathologies (13 papers) and Neurological Complications and Syndromes (8 papers). A. Elli collaborates with scholars based in Italy, United States and Switzerland. A. Elli's co-authors include F. Quarto di Palo, R Rivolta, D Castagnone, Giuseppe Bianchi, F. Fabrizi, Claudio Ponticelli, Vivek Dixit, Giuseppe Vezzoli, G. Montagnino and P. J. Martin and has published in prestigious journals such as New England Journal of Medicine, American Journal of Kidney Diseases and Transplantation.

In The Last Decade

A. Elli

44 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Elli Italy	15	169	141	124	121	106	47	547
Gagnadoux Mf France	13	112 0.7×	80 0.6×	71 0.6×	201 1.7×	85 0.8×	42	480
Matthias Büchler France	9	211 1.2×	91 0.6×	97 0.8×	134 1.1×	141 1.3×	20	567
Jackson Joe Yium United States	12	103 0.6×	148 1.0×	122 1.0×	207 1.7×	50 0.5×	21	674
K.-H. Shu Taiwan	12	97 0.6×	87 0.6×	149 1.2×	144 1.2×	77 0.7×	38	493
T. Messiaen Belgium	16	124 0.7×	217 1.5×	154 1.2×	202 1.7×	60 0.6×	29	739
Stephen D. Migdal United States	12	93 0.6×	74 0.5×	98 0.8×	127 1.0×	98 0.9×	17	422
Makoto Tsujita Japan	17	292 1.7×	133 0.9×	172 1.4×	227 1.9×	113 1.1×	64	702
Eileen W. Tsai United States	14	324 1.9×	119 0.8×	143 1.2×	129 1.1×	51 0.5×	16	647
Verónica López Spain	14	152 0.9×	81 0.6×	124 1.0×	94 0.8×	74 0.7×	54	544
J. M. Grinyó Spain	10	265 1.6×	91 0.6×	181 1.5×	92 0.8×	177 1.7×	28	551

Countries citing papers authored by A. Elli

Since Specialization

Citations

This map shows the geographic impact of A. Elli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Elli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Elli more than expected).

Fields of papers citing papers by A. Elli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Elli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Elli. The network helps show where A. Elli may publish in the future.

Co-authorship network of co-authors of A. Elli

This figure shows the co-authorship network connecting the top 25 collaborators of A. Elli. A scholar is included among the top collaborators of A. Elli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Elli. A. Elli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Corradini, C., Marco Macchia, E. Malagoli, et al.. (2010). Sequential use of teriparatide and risedronate in multifractured severe osteoporosis: Clinical results at 30 month F.U. Bone. 47. S198–S198.

2.

Elli, A., et al.. (2009). Teriparatide from day 15 by operation in osteoporotic femoral fractures for a satisfactory functional outcome at two years follow-up. Bone. 44. S427–S427. 1 indexed citations

3.

Mandolfo, S., et al.. (2006). Catheter lock solutions: it's time for a change. The Journal of Vascular Access. 7(3). 99–102. 8 indexed citations

4.

Fabrizi, F., et al.. (2006). Meta‐analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Alimentary Pharmacology & Therapeutics. 24(3). 497–506. 64 indexed citations

5.

Fabrizi, F., Jonathan S. Bromberg, A. Elli, Vivek Dixit, & Paul Martin. (2005). Review article: hepatitis C virus and calcineurin inhibition after renal transplantation. Alimentary Pharmacology & Therapeutics. 22(8). 657–666. 16 indexed citations

6.

Luzi, Livio, Lucia Piceni Sereni, Alberto Battezzati, et al.. (2003). Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant. Transplantation. 75(12). 2018–2023. 19 indexed citations

7.

Elli, A., F. Quarto di Palo, R Rivolta, et al.. (2000). Effect of increased arterial resistance index on long-term outcome of well-functioning kidney grafts. Transplant International. 13(0). S84–S89. 3 indexed citations

8.

Elli, A., F. Quarto di Palo, R Rivolta, et al.. (2000). Effect of increased arterial resistance index on long-term outcome of well-functioning kidney grafts. Transplant International. 13(S1). S84–S89. 3 indexed citations

9.

Ponticelli, Claudio, A. Aroldi, A. Elli, et al.. (1999). The clinical status of cadaveric renal transplant patients treated for 10 year with cyclosporine therapy. Clinical Transplantation. 13(4). 324–329. 13 indexed citations

10.

Richardet, Eduardo, E. Mickiewicz, Guillermo Lerzo, et al.. (1999). Uracil/tegafur plus oral calcium folinate in advanced breast cancer.. PubMed. 13(7 Suppl 3). 96–7. 6 indexed citations

11.

Battezzati, Alberto, Stefano Benedini, Giorgio Maria Calori, et al.. (1998). Spontaneous hypoglycaemia after pancreas transplantation in Type 1 diabetes mellitus. Diabetic Medicine. 15(12). 991–996. 12 indexed citations

12.

Miadonna, A., et al.. (1998). Fibrillary Glomerulonephritis in Castleman's Disease. Leukemia & lymphoma. 28(3-4). 429–435. 10 indexed citations

13.

Aroldi, A., Pietro Lampertico, A. Elli, et al.. (1998). Long-term evolution of anti–HCV-positive renal transplant recipients. Transplantation Proceedings. 30(5). 2076–2078. 14 indexed citations

14.

Montagnino, G., et al.. (1997). Prognostic factors of long-term allograft survival in 632 CyA-treated recipients of a primary renal transplant. Transplant International. 10(4). 268–275. 20 indexed citations

15.

Palo, F. Quarto di, R Rivolta, A. Elli, & D Castagnone. (1996). Relevance of Resistive Index Ultrasonographic Measurement in Renal Transplantation. Nephron. 73(2). 195–200. 24 indexed citations

16.

Rivolta, R, B. Mascagni, F. Quarto di Palo, et al.. (1996). Renal vascular damage in systemic sclerosis patients without clinical evidence of nephropathy. Arthritis & Rheumatism. 39(6). 1030–1034. 33 indexed citations

17.

Palo, F. Quarto di, R Rivolta, A. Elli, et al.. (1993). Effect of Cyclosporin A on Renal Cortical Resistances Measured by Color Doppler Flowmetry on Renal Grafts. The Nephron journals/Nephron journals. 65(2). 240–244. 21 indexed citations

18.

Bianchi, Giuseppe, Giuseppe Vezzoli, Daniele Cusi, et al.. (1988). Abnormal Red-Cell Calcium Pump in Patients with Idiopathic Hypercalciuria. New England Journal of Medicine. 319(14). 897–901. 36 indexed citations

19.

Vezzoli, Giuseppe, et al.. (1986). Ca-ATPase in Erythrocyte Membrane Ghost Cells of MHS Rats. American Journal of Nephrology. 6(1). 63–65. 1 indexed citations

20.

Cusi, Daniele, et al.. (1986). Effects of captopril and of other antihypertensive drugs on cell membrane ion transport--a preliminary report.. PubMed. 62 Suppl 1. 13–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact